Literature DB >> 28689166

Ocular surface cytokine profile in chronic Stevens-Johnson syndrome and its response to mucous membrane grafting for lid margin keratinisation.

Srividya Gurumurthy1, Geetha Iyer2, Bhaskar Srinivasan3, Shweta Agarwal3, Narayanasamy Angayarkanni4.   

Abstract

BACKGROUND: To study the tear cytokine and the conjunctival and oral mucosal marker profile in chronic ocular Stevens-Johnson syndrome (SJS) and their alteration following mucous membrane grafting (MMG) for lid margin keratinisation (LMK).
METHODS: In a 1-year prospective study, SJS cases (n=25) and age-matched/sex-matched healthy controls (n=25) were recruited. Tear specimen (Schirmer's strip), conjunctival and oral mucosal imprints were collected from controls and SJS cases pre-MMG and post-MMG (at first follow-up, n=17). Tear cytokines were profiled using 27-bioplex array. Transforming growth factor-beta (TGF-β)-mediated extracellular matrix changes in conjunctival and oral mucosal cells were analysed by gene expression studies. 30
RESULTS: Tear cytokine profiling of chronic SJS cases at pre-MMG stage revealed significant upregulation of cytokines granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-8, IL-1β, monocyte chemoattractant protein-1, IL-15, IL-2, IL-17A and basic fibroblast growth factor (bFGF) with downregulation of IP-10 (interferon gamma-induced protein 10), tumour necrosis factor-α, interferon-γ, IL-10, vascular endothelial growth factor, regulated upon activation normal T-cell expressed and secreted (RANTES), IL-7, IL-12p70 and IL-13, with maximal increase in GM-CSF and maximal downregulation of IP-10, respectively. Of these, IL-2, IL-15, bFGF and IL-17A showed significant correlation with disease severity, pre-MMG. Conjunctival cells pre-MMG showed increase in TGF-β1, TGF-βRII, connective tissue growth factor and collagen-III gene expression by 10, 67, 173 and 184 folds, respectively, which dropped to 1.3, 11, 13.5 and 19 folds correspondingly, post-MMG. However, their expressions in oral mucosa were negligible.
CONCLUSION: A proinflammatory, profibrotic, antiapoptotic ocular surface milieu characterises chronic ocular SJS. IP-10, an antifibrotic cytokine was noted to be maximally downregulated, unlike in other forms of chronic dry eye disease. The alterations in the ocular surface are seen to reverse largely with MMG for LMK. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Inflammation

Mesh:

Substances:

Year:  2017        PMID: 28689166     DOI: 10.1136/bjophthalmol-2017-310373

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Altered mucins and aquaporins indicate dry eye outcome in patients undergoing Vitreo-retinal surgery.

Authors:  Ramalingam Mani; P S Shobha; Saravanan Thilagavathi; Padmanabhan Prema; Natarajan Viswanathan; Ratra Vineet; Ratra Dhanashree; Narayanasamy Angayarkanni
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 2.  Role of tear film biomarkers in the diagnosis and management of dry eye disease.

Authors:  Pak Yui Fong; Kendrick Co Shih; Pun Yuet Lam; Tommy Chung Yan Chan; Vishal Jhanji; Louis Tong
Journal:  Taiwan J Ophthalmol       Date:  2019-09-12

3.  Mucous membrane grafting for lid margin keratinization in Stevens Johnson syndrome - An eye opening saga.

Authors:  Geetha Iyer
Journal:  Indian J Ophthalmol       Date:  2021-04       Impact factor: 1.848

Review 4.  A beginner's guide to mucous membrane grafting for lid margin keratinization: Review of indications, surgical technique and clinical outcomes.

Authors:  Swapna S Shanbhag; Swati Singh; Puduchira George Koshy; Pragnya Rao Donthineni; Sayan Basu
Journal:  Indian J Ophthalmol       Date:  2021-01-28       Impact factor: 1.848

5.  Development of a novel hyaluronic acid membrane for the treatment of ocular surface diseases.

Authors:  Dong Ju Kim; Mi-Young Jung; Ha-Jin Pak; Joo-Hee Park; Martha Kim; Roy S Chuck; Choul Yong Park
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

Review 6.  Vulvovaginal and ocular involvement and treatment in female patients with Stevens-Johnson syndrome and toxic epidermal necrolysis: A review.

Authors:  M Teresa Magone; Mary Maiberger; Janine Clayton; Helena Pasieka
Journal:  Int J Womens Dermatol       Date:  2021-09-02

Review 7.  Differential expression of tear film cytokines in Stevens-Johnson syndrome patients and comparative review of literature.

Authors:  Madhuri Amulya Koduri; Deeksha Prasad; Shriya Upadhyaya; Jilu Jaffet; Swapna S Shanbhag; Sayan Basu; Vivek Singh
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.379

Review 8.  Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).

Authors:  E C Kuijper; L E French; C P Tensen; M H Vermeer; J N Bouwes Bavinck
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

9.  Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis.

Authors:  Yamato Yoshikawa; Mayumi Ueta; Hiromi Nishigaki; Shigeru Kinoshita; Tsunehiko Ikeda; Chie Sotozono
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

10.  Benzalkonium chloride-induced myofibroblastic transdifferentiation of Tenon's capsule fibroblasts is inhibited by coculture with corneal epithelial cells or by interleukin-10.

Authors:  Chiemi Yamashiro; Kazuhiro Tokuda; Yuka Kobayashi; Fumiaki Higashijima; Takuya Yoshimoto; Manami Ota; Tadahiko Ogata; Atsushige Ashimori; Masaaki Kobayashi; Makoto Hatano; Sho-Hei Uchi; Makiko Wakuta; Shinichiro Teranishi; Kazuhiro Kimura
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.